AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present a company overview and update at the 26th Annual Canaccord Adams Summer Seminar on Thursday, August 10, 2006, at 8:00 a.m. EDT at The Boston Marriott Long Wharf in Boston, Massachusetts. A live audio webcast of the prese
